Calcineurin inhibitors (CNIs) are a significant component of the immunosuppressive regimen after kidney transplantation. By inhibiting cytokine gene transcription, CNIs suppress T cell and T cell-dependent B cell activation. Tacrolimus is preferred in most patients undergoing kidney transplantation. Thrombotic microangiopathy (TMA) is a severe but rare complication of CNIs therapy. TMA defines a specific pathologic lesion of arterioles and capillaries that leads to microvascular thrombosis. A 45-year-old male underwent kidney transplantation five months ago due to autosomal dominant polycystic kidney disease (ADPKD). His triple-maintenance immunosuppressive therapy includes tacrolimus. Abdominal pain and bloody diarrhea occurred in the fifth month of posttransplant. The edematous and erythematous mucosa of the ascending colon was detected on the colonoscopy. The foci of microthrombi inside the vessel lumen in the lamina propria were shown biopsy. The thrombosis or occlusion was excluded with computerized tomography (CT) angiography in abdominal vessels. The fragmented red blood cells and moderate thrombocytopenia were detected on the peripheral blood smear. Eventually, TMA diagnosis was established through laboratory and histological findings. Tacrolimus was suspected as the trigger of the pathological process and promptly switched to the everolimus. Afterward, laboratory abnormalities and clinical symptoms were improved. In this case, we intend to emphasize drug-associated TMA and atypical presentations, such as colonic microvasculature involvement.
Background: Acute pancreatitis (AP) evolves during the first days of hospitalization, and the prognostic value of complete blood count (CBC)-derived inflammatory indices may depend on measurement timing. We evaluated serial neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and systemic immune-inflammation index (SII) values and their associations with disease severity, pancreatic necrosis, and prolonged hospitalization. Methods: This retrospective single-center study included 299 adults hospitalized with AP between 2010 and 2020. NLR, PLR, and SII were assessed at admission, 24 h, and 48 h. Temporal changes and between-group differences were analyzed, and discriminatory performance was evaluated using receiver operating characteristic analysis. Results: NLR, PLR, and SII decreased over time in the overall cohort but remained higher in patients with moderate-to-severe AP. Admission PLR had the highest observed AUC for moderate-to-severe AP (0.738). Admission values did not significantly distinguish patients with pancreatic necrosis, whereas 48-h SII had the highest observed AUC for necrosis (0.810; sensitivity 82.35%; specificity 76.95%). For hospitalization > 4 days, 48-h NLR had the highest observed AUC (0.742). Conclusions: Observed discriminatory performance varied according to both measurement timing and clinical outcome. Later measurements showed greater numerical discrimination for pancreatic necrosis and prolonged hospitalization than admission values. These findings are exploratory, and the proposed cut-offs require external validation.